Characterized by mucocutaneous bleeding arising from a lack of platelet aggregation to physiologic stimuli, Glanzmann thrombasthenia (GT) is the archetype-inherited disorder of platelets. Transmitted by autosomal recessive inheritance, platelets in GT have quantitative or qualitative deficiencies of the fibrinogen receptor, αIIbβ3, an integrin coded by the ITGA2B and ITGB3 genes. Despite advances in our understanding of the disease, extensive phenotypic variability with respect to severity and intensity of bleeding remains poorly understood.
7 knowledge on integrin function. Functional studies suggest further heterogeneity, platelets from the above-mentioned type II French patient and two French patients with variant GT (ITGB3, Ser752Pro; ITGB3 Arg214Trp) although unable to bind Fg, adhered and formed small thrombi when their blood was perfused through collagen-coated capillaries. 22 A thick mesh composed of VWF and fibrin surrounded the thrombi suggesting residual shear-dependent platelet reactivity.
In contrast, thrombi were not observed for two GT patients totally lacking αIIbβ3. But, such phenotypic differences did not correlate with bleeding history.
Integrin αvβ3 in thrombasthenia
Platelets of Israeli-Arabs with an ITGA2B mutation (c.IVS3(-3)-418del + frameshift) preventing αIIbβ3 expression had a twofold increase in αvβ3. Platelets of Iraqi-Jewish patients with an ITGB3 mutation (c.2031-2041del/premature termination) lacked both integrins but contained fivefold more Vn while still not storing Fg. 10, 23, 24 It was proposed that Vn, synthesized in MKs, is normally transported out of the cells by αvβ3 largely localized to small vesicular structures in platelets. 25 Nevertheless, clinically, the Iraqi-Jewish and Arab patients are indistinguishable.
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Some β3 mutations (e.g. Leu196Pro and His280Pro, a mutation prevalent in Japan) primarily affect αIIbβ3 but not αvβ3 expression. [27] [28] [29] Ligand binding to the integrins may also be differentially impaired; e.g. αIIbβ3196Pro supported CHO cell spreading on Fg, but αvβ3196Pro
did not and the difference extended to clot retraction. As αvβ3 is expressed in endothelial cells, osteoclasts, smooth muscle cells among others, such results imply that the effect of β3 amino acid substitutions on these cells must be assessed individually.
Variant-type GT
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Obligate heterozygotes for GT have platelets with intermediate amounts of αIIbβ3 but normal platelet function and they do not bleed. 1, 2 In variant-type GT, patients express αIIbβ3 at levels that would normally allow platelet aggregation, but amino acid substitutions render the integrin non-functional. Variants are diagnosed through the inability of their platelets to bind labeled-Fg or antibodies recognizing activation-dependent determinants on αIIbβ3. 30 The nature and position of the mutation defines the residual functional response. Significantly, most of them concern ITGB3. Table I summarizes the platelet characteristics of the most studied cases of variant GT.
(i) Mutations affecting extracellular domains of β3. The first variant to be characterized was from Guam and possessed a homozygous Asp119Tyr substitution in β3 (Fig. 2) . 31 This occurs within the β3 I-like domain and interferes with the function of αIIbβ3 and αvβ3 by inducing the loss of a divalent cation (Mg 2+ ) structured Fg-binding site within the metal iondependent adhesion site (MIDAS). 4 Three unrelated patients (two from France and one from Australia; all with moderate to severe bleeding, Table I ) possessed homozygous substitutions of Arg214 (Arg214Gln or Trp) in the ADMIDAS (adjacent to MIDAS) Ca 2+ -binding domain of β3 (Fig. 2) . [32] [33] [34] [35] [36] [37] These substitutions made αIIbβ3 unstable, sensitive to divalent-cation chelation and unable to bind Fg; they not only prevent aggregation, they also stop clot retraction and platelet Fg capture reinforcing the idea that αIIbβ3 is required for each task. Although three-dimensional structures of the unactivated and activated (Fg-binding) forms of αIIbβ3 have been defined and key residues essential for Fg binding located on both the β3 MIDAS and ADMIDAS domains; 3, 4, 36 ,37 different structural requirements may be required for clot retraction and Fg trafficking. This is underlined by a homozygous β3 Ser162->Leu mutation situated near the synergistic metal binding site (SyMBS) (Fig. 2 ) in a patient whose platelets fail to aggregate but
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From undergo clot retraction. 38 Platelet expression of αIIbβ3 was assessed as 16-27%, but discrepant monoclonal antibody binding suggested altered complex-dependent determinants, a situation repeated for a β3Leu262Pro substitution. 39 A β3 Arg93Gln mutation also supported clot retraction but not aggregation; significantly, a patient with homozygous expression had a milder bleeding syndrome and greater αIIbβ3 expression than a second patient who associated the variant allele with a null allele. 18 A homozygous Ser123Pro substitution was detected in β3 in an
Indian girl with the clinical signs of GT but normal platelet αIIbβ3 expression. 40 Paradoxically, ADP-induced Fg binding still occurred despite a lack of aggregation to ADP and collagen, a finding that needs further explanation.
(ii) β3 cytoplasmic domain mutations. Platelets from a South-American man with a mild bleeding history expressed 50% αIIbβ3 but failed to aggregate or bind Fg when stimulated.
Nevertheless, his platelets supported clot retraction and possessed a normal α-granule pool of Fg (Table I) . 41, 42 A heterozygous Ser752Pro substitution in the β3 cytoplasmic tail (Fig. 2) accounted for the defect and was said by the authors to be associated with a null allele on the basis that his daughter's platelets, which also expressed 50% αIIbβ3, aggregated normally but did not possess the β3 cytoplasmic domain mutation. 41 In modifying β3 intracytoplasmic domain structure ( Fig. 2) , Pro752 not only abrogates αIIbβ3 and αvβ3 activation it also blocks "outsidein signaling" and cell spreading after integrin engagement on surface-bound adhesive proteins. bleeding whose platelets aggregated minimally to ADP but gave a slow, irreversible aggregation to thrombin. 60,61 Levels of αIIbβ3 were at the lower limit of those able to support aggregation.
Moderate thrombocytopenia and anisocytosis with large platelets were linked to a paternally inherited heterozygous Arg995Gln substitution within the GFFKR sequence of the cytoplasmic domain of αIIb (Fig. 2) . PAC-1 binding to a stably transfected CHO cell line showed the mutated integrin to be partially activated; nonetheless it failed to spontaneously bind Fg. A maternally inherited heterozygous intronic deletion (c1440-13_1440-1del) within the splicing acceptor for exon 15 led to an absent expression of the second allele for αIIb and largely accounted for the low αIIbβ3 content. 62 The subsequent observation that a heterozygous ITGA2B Arg995Trp mutation in 5 patients from 3 Japanese families gave a similar phenotype made it unlikely that a co-expressed second mutation accounts for the macrothrombocytopenia. 63 In the Japanese families, a normal second allele meant that surface αIIbβ3 levels were 50% to 70% of controls.
Spontaneous binding of PAC-1 to platelets and studies on αIIb995Trpβ3-transfected 293T cells confirmed the mutated integrin to be partially activated, that is to say to have undergone conformational changes allowing PAC-1 access to its binding site. Cytoplasmic domain residues αIIbArg995 and β3Asp723 form a salt bridge and breaking this clasp is thought to be a key step in integrin activation. 64 Significantly, macrothrombocytopenia but without a platelet aggregation defect (thereby showing that β3 mutations can extend beyond the GT phenotype) characterized 5 members of a family with a heterozygous partially activating Asp723His substitution in β3, a substitution that has a considerable charge effect. 
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In two Italian families, severe mucocutaneous bleeding, moderate thrombocytopenia and large platelets with defective aggregation were inherited as an autosomal dominant trait (Table   I) . 66 Molecular analysis revealed a heterozygous in-frame deletion causing loss of amino acids 647-686 from the transmembrane domain of β3. A dominant negative effect was hypothesized.
The result was a low surface expression of αIIbβ3 but PAC-1 binding was not significantly 
LAD-3 syndrome
In leukocyte adhesion deficiency (LAD) syndromes, mutations with loss of function of β2 integrins on leukocytes (LAD-1) or altered fucosylation of glycoproteins (LAD-2) give rise to immune-deficiency syndromes associated with a defective inflammatory response and infections.
In LAD-3, patients associate a greater bleeding severity (including intracerebral bleeding) with immune deficiency and recurrent infections but with a normal expression of β1, β2 and β3
integrins. 68,69 These patients have a defect common to the "inside-out" signaling pathways of the integrins. Infections range from bacterial pneumonia and early septicemia to fungal disease; osteopetrosis in some patients indicates abnormal osteoclast function. Initial studies implied that LAD-3 patients were deficient in a guanine nucleotide exchange factor, CALDAG-GEFI, and that this led to decreased Rap1 activation. 70 However, mutations in FERMT3 (encoding kindlin-3) were later found to account for the phenotype. 46,71-74 Kindlin-3 belongs to a family of proteins that cooperate with talin in inside-out integrin activation. 73 Possessing a single FERM (F) domain with 3 subdomains, kindlin-3 binds through its third subdomain (F3) to the membrane distal NXXY motif of the β-integrin cytoplasmic tail; this differs from talin that binds to the membrane proximal NXXY motif. 73 Significantly, kindlin-3 binding was abrogated by the GT variant β3
Ser752Pro mutation (see Section on Variant-type GT) again raising questions as to his mild bleeding phenotype 71 . Stop codons or splicing defects leading to truncation and/or nonexpression of kindlin-3 predominate in LAD-3 patients. could alone explain this finding. 78 Although the HPA-1b allele has a low gene frequency of 0.15 in Caucasians; we noted that it predominated in French gypsies with GT and a moderate to severe bleeding phenotype. 79 These patients have a G>A substitution at the splice donor site of intron 15
in ITGA2B (Supplemental Fig. 1 ) and platelets totally lacking αIIbβ3. The frequency of major SNPs on GPIbα, GPVI or the α2 integrin subunit have not shown consistent changes in expression in the small GT cohorts so far examined; 76, 79 nonetheless, a much larger study is warranted in view of the wide range of expression of these adhesion receptors on platelets of normal donors.
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Frequency of major pathologies associated with GT
A number of major pathologies have been reported in GT patients although their frequency and link to the genetic defect causative of GT have yet to be adequately evaluated. Supplemental Table II 
LAD-3). GT in a German woman with developmental defects including skeletal abnormalities
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It is reasonable to ask whether metastasis and cancer development are modified in GT for platelets facilitate cancer cell adhesion to subendothelium and metastasis while αvβ3 is involved in tumor angiogenesis (reviewed in 81 ). Several reports have featured surgical removal of carcinoma in GT patients (Supplemental Table II ). In Bordeaux, an elderly type II GT male patient (with an approximate 10% surface αIIbβ3 expression, a lack of platelet aggregation, subnormal clot retraction and moderate bleeding syndrome) died from the consequences of lung cancer with brain metastasis (P. Nurden, unpublished observations May, 2011). Xeroderma pigmentosum, an autosomal recessive condition characterized by severe sun sensitivity, early skin cancers and abnormal DNA repair occurred in a 12 year-old Turkish girl with GT. Acute myeloid leukemia (AML) was described in a Japanese GT patient from Hiroshima with a novel point mutation in ITGA2B, bone marrow transplantation from a HLA-matched donor was successfully performed.
Atherosclerosis and coronary artery disease have also been reported in GT (see Supplementary Table II for details). The most comprehensive study is the screening of seven Israeli GT patients (46-66 yrs) belonging to the Arab (lacking αIIbβ3) or the Iraqi-Jew cohorts (lacking both αIIbβ3 and αvβ3) for early signs of atherosclerosis. An increased intima/media thickness and atherosclerotic plaques in 5 of them confirmed that atherosclerosis can occur.
Several isolated reports also describe cardiac or ischemic problems in GT patients (detailed in Supplementary Table II) . However, these need to be assessed with caution in view of the absence of mutation screening. Overall it is difficult to assess incidence of cardiovascular disease in GT in view of the young age of many patients. 
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Interestingly, several cases of DVT have been reported in patients with GT (detailed and referenced in Supplemental Table II women who attempted to become pregnant succeeded. Secondary amenorrhea due to repeated ovarian hemorrhage was suggested to contribute to the fertility problem. An unexpected low number of pregnancies and a high frequency of spontaneous abortions have been reported in GT women in a large epidemiological study in Iran. 84 The consequences of the absence of αIIbβ3 and αvβ3 in ovulation as well as placental and fetal development requires further clarification.
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Mouse models with deficiencies of αIIbβ3 and αvβ3
Transgenic mouse models offer a clearer picture of the influence of integrin deletion in nonhemostatic processes. While mice are not humans and differences between clinical findings in patients and mice may be a reflection of species differences, it is worthwhile to look at the studies on β3 and αIIb deficient mice. The first report of β3-integrin deficient mice, underlined that while they reproduced the GT bleeding phenotype, there were diverse embryonic and postnatal changes. 85 Placental defects were seen and these led to an increased fetal mortality, a finding suspected but as yet unproven in human GT (see preceding Section). Unexpectedly, mice lacking β3 not only supported tumorigenesis, tumor growth was actually improved. 86 Enhanced angiogenesis in the β3 null mice was linked to an unexpected increase in the platelet storage pool of VEGF and elevated levels of VEGF receptor-2 (Flk-1) on endothelial cells. 87 Enhanced Flk1
signaling allowed increased endothelial cell migration and proliferation in response to VEGF as well as greater VEGF-mediated permeability.
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Enigmatically, coronary capillaries fail to mature in male but not female β3-null mice.
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Its correction by blocking VEGF implies that αvβ3 plays a critical role in coronary vascular development and the vascular response to VEGF. Cardiac hypertrophy (with systolic and diastolic dysfunction) and accelerated atherosclerosis were also noted in  β3-deficient mice. 90 An increased macrophage infiltration in β3-/-cardiac tissue was associated with a greater expression of inflammatory genes such as those encoding IL-1β, Il-6 and TNF-α. 91 When apoE-null and LDL receptor-null mice were transplanted with β3-deficient marrow, they showed increased atherosclerosis and a higher mortality with Western-type high fat feeding. Multiple knockouts obtained by crossing β3-/-mice with apoE-/-and LDR receptor -/-mice again showed how β3-deficiency was associated with more atherosclerosis while a high frequency of fatal pneumonitis
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Accelerated re-epithelialization is a feature of β3-deficient mice as a result of an increase in TGFβ1 and enhanced migration of dermal fibroblasts into wounds. 93 It was suggested that αvβ3 can suppress TGF-β1-mediated signaling and control the rate of wound healing. However defective bone re-sorption was confirmed in β3 -/-mice. Dysfunctional osteoclasts resulted in age-dependent osteosclerosis; a finding also reproduced in mice genetically engineered to express the β3 variant Ser752Pro mutation. 94,95 Injection of B16 melanoma cells into β3 -/-mice led to osteolytic bone metastasis in 74% of wild-type mice but only in 4% of β3 -/-mice. It was concluded that αIIbβ3 has a role in tumor cell entry into bone and that αvβ3 in osteoclasts is essential for bone resorption. 96 These studies confirm much earlier work from the Karpatkin group who showed that the MoAb 10E5 reactive with αIIbβ3 afforded protection against metastases in a mouse model reconstituted with human platelets. 97 Morgan et al 8 using Cre/loxP technology in mice showed that conditional depletion of myeloid β3-integrins (including from osteoclasts) but not from platelets resulted in osteopetrosis (with significant increases in trabecular bone volume) but no bleeding. Tumor growth in these mice was also increased and accompanied by decreased macrophage infiltration confirming an earlier study. 8, 98 This strongly underlines how β3-integrins have cell-specific roles. Interestingly, osteopetrosis appears more of a problem in LAD-3 disease, a finding linked to the role for kindlin-3 in activation of 3 integrin classes (β1, β2 and β3) expressed on osteoclasts and abrogating the formation of podosomes and sealing zones required for bone resorption. 99 Remarkably, β3 knockout mice also show abnormal behaviour patterns suggesting that β3 is involved in brain changes relevant to autism spectrum disorder.
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Relatively few studies have been performed on αIIb deficient mice, in the first model restricted to blood cells, Tronik-Le Roux et al while confirming the thrombasthenic phenotype also noted that Itga2b is expressed in murine hematopoietic progenitors. 101 Subsequent studies showed that inactivation of Itga2b led to increased liver and bone marrow progenitor numbers and led to the unexpected finding that αIIbβ3 was expressed on mast cells and that it may influence their differentiation and homing, a finding not yet extrapolated to human disease.
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Final conclusions
GT through the numbers of patients affected and the distinct bleeding phenotype is the principleinherited disorder of an integrin. In contrast to the results obtained for knockout mice, the absence or nonfunctioning of αvβ3 in endothelium, bone and other tissues including placenta has yet to be shown to create a distinct phenotype. The gene encoding αv (ITGAV) is found at chromosome 2q32; remarkably, no mutations have been reported to give inherited disease. While this may suggest that αv is embryonically lethal, the absence of β3 is not and so the alternative explanation is that the role of αvβ3 can be taken over by other integrins. Also, ITGB3 missense mutations may affect the expression and/or function of αIIbβ3 and αvβ3 differently (see section on integrin αvβ3 in thrombasthenia) giving a different situation to that in most transgenic mouse models where mice totally lack expression of the β3 gene. Yet the results for β3-deficient mice clearly emphasize that post-menopausal bone thickening and the susceptibility of GT patients to have cancer and cardiovascular disease needs urgent clarification. GT patients are certainly not protected against venous thrombosis which might be in line with recent studies in mouse models
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From pointing to a role for the GPIb/VWF axis in DVT. 103 The incidence of inflammation in GT patients is also unknown. Studies on large ethnic groups with a predominating mutation may help define phenotypic heterogeneity. Importantly, genotyping within epidemiological studies is progressing fast and it is to be hoped that an International collaboration with the inclusion of 400 or 500 genotyped patients will soon be possible. This will allow the separation of distinct cohorts, the application of a standardized bleeding score, and provide a more complete comparison of the different parameters emphasized in this review. 
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For Mutations giving rise to GT are distributed across both genes. In contrast, variant forms are more likely to have β3 gene defects (see also Table I ). 
